Background: Data are lacking on the efficacy and safety of a loading dose of clopidogrel in the elderly with acute myocardial infraction (AMI).
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Aim:
To determine 30-day and one-year mortality, as well as in-hospital bleeding risk in elderly patients with AMI according to the use of a loading dose of clopidogrel ( ≥ 300 mg).
Methods:
FAST-MI is a nationwide registry carried out over a 1-month period in 2005, including consecutive patients with AMI admitted to ICUs < 48 hours from symptom onset in 223 participating centers. We assessed impact of clopidogrel loading dose on bleeding, the need for blood transfusion and 12-month survival in elderly patients (aged ≥ 75 years).
Results: 791 elderly patients were included (Mean age 81 ± 4 years, 48 % women; 35% STEMI). 59% (466 patients) have received a clopidogrel loading dose ( ≥ 300mg). Follow up was > 98% complete. Major bleeding and blood transfusions were not significantly different in patients having received a loading dose of clopidogrel or a conventional 75 mg dose, respectively 3.7 vs. 3.2 (p>0,05) and 6.2 vs. 5.4 (p>0,05). Early and one-year mortality were also not significantly different. Using multivariate analyses: Clopidogrel loading dose was not associated with a significant increase major bleeding or transfusion (OR=1.09; 95%CI:0.50-2.40, p=0.82); and 12-month mortality (OR=0.95; 95%CI:0.65-1.29, p=0.61).
Conclusion:
The present data show that in elderly patients admitted for AMI, use of a loading dose of clopidogrel was not associated with increased in-hospital bleeding, need for transfusion, or mortality. These results persisted after mutivariate adjustment. Large-scale randomized trials are still needed to identify the optimal loading dose of clopidogrel for elderly patients admitted for AMI. Background: It has been suggested that delays, quality and outcome of reperfusion therapy provided to ST-Elevation Myocardial Infarction (STEMI) patients during OFF-hours (nights and weekend) are worse than during ONhours (day working hours).
Methods:
We studied 736 consecutive STEMI patients transferred for primary percutaneous intervention (PCI) to a single large volume urban Primary PCI center. Characteristics and clinical outcome of patients admitted during ON-hours (Monday through Friday 8 am-6 pm) were compared to OFF-hours patients (admitted during night shifts and weekends). Clinical outcome was 1 year death and death or MI.
Results: STEMI patients undergoing primary PCI were admitted more frequently during OFF-hours (n=449; 61.1%) than ON-hours (n=287; 38.9%), with no major differences in characteristics or treatment between the two groups. Use of radial approach and the rate of stenting during PCI was 83.3% and 86.1% in ON-hours patients vs. 88.2%.and 88.1% in OFF-hours patients. There was no impact of time of admission on in-hospital mortality before or after adjustment for baseline characteristics OR 1.54; . Time from symptom onset to first medical contact was shorter during OFF-hours than vs. 114 min ; p=0.06). Time from first medical contact to sheath insertion was also identical between the 2 groups (101 min and 105 min ; p=0.61 respectively). Time to TIMI 3 flow and duration of procedure were also similar. At one year, all cause mortality and the composite end point of death or MI was 8.3% and 12.2% for OFF-hours patients vs. 7.0% and 10,8% in ON-hours patients, p=0.4 and p=0.3 respectively.
Conclusion:
In a well-organized urban STEMI network, were 61% of patients referred for primary PCI are admitted during "OFF" hours, admission time does not impact quality of care or outcomes.
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